In Reply
- PMID: 32217954
- DOI: 10.1097/AOG.0000000000003782
In Reply
Comment on
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Jan;135(1):158-165. doi: 10.1097/AOG.0000000000003620. Obstet Gynecol. 2020. PMID: 31809439 Clinical Trial.
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Apr;135(4):969-970. doi: 10.1097/AOG.0000000000003780. Obstet Gynecol. 2020. PMID: 32217951 No abstract available.
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Apr;135(4):970. doi: 10.1097/AOG.0000000000003786. Obstet Gynecol. 2020. PMID: 32217952 No abstract available.
-
Mifepristone Antagonization With Progesterone to Prevent Medical Abortion: A Randomized Controlled Trial.Obstet Gynecol. 2020 Apr;135(4):970. doi: 10.1097/AOG.0000000000003781. Obstet Gynecol. 2020. PMID: 32217953 No abstract available.
References
-
- Creinin MD, Hou MY, Dalton L, Steward R, Chen MJ. Mifepristone antagonization with progesterone to prevent medical abortion: a randomized controlled trial. Obstet Gynecol 2020;135:158–65.
-
- Delgado G, Condly SJ, Davenport M, Tinnakornsrisuphap T, Mack J, Khauv V, et al. A case series detailing the successful reversal of the effects of mifepristone using progesterone. Issues Law Med 2018;33:21–31.
-
- Upadhyay UD, Desai S, Zlidar V, Weitz TA, Grossman D, Anderson P, et al. Incidence of emergency department visits and complications after abortion. Obstet Gynecol 2015;125:175–83.